On May 5, 2026, Germany’s Federal Ministry for the Environment enacted the MedGreen Verordnung (Medical Devices Green Access Regulation), requiring all medical devices imported into Germany—including imaging systems, diagnostic instruments, and sterilization equipment—to be accompanied by a third-party certified ‘Sustainability Declaration’ starting Q3 2026. This development directly impacts medical device exporters, especially those in China, and signals a tightening of environmental compliance requirements at the EU market access level.

Event Overview

The MedGreen Verordnung entered into force on May 5, 2026. From Q3 2026 onward, all medical devices placed on the German market must include a verified Sustainability Declaration disclosing: (1) carbon footprint of core component raw materials (kg CO₂e/kg), (2) recyclability rates (%) for metals and plastics, and (3) share of recycled content in packaging. Chinese exporters must add an Environmental Product Declaration (EPD) as a new attachment to their CE certification dossier.

Which Subsectors Are Affected

Direct Exporters (Especially Chinese Manufacturers)

These companies face immediate regulatory obligations when placing devices on the German market. The requirement adds a new mandatory documentation layer beyond existing CE conformity assessments—specifically, the EPD must be third-party verified and integrated into the technical file submitted to Notified Bodies or national authorities.

Raw Material Suppliers (Metals, Plastics, Packaging Providers)

Suppliers are indirectly but critically affected: manufacturers can only generate accurate carbon footprint and recyclability data if upstream material specifications—including origin, processing energy, and recycled content—are transparently provided. Absence of such data may block downstream EPD preparation.

Contract Manufacturers & OEMs

Entities assembling or branding devices for export must ensure traceability across sub-assemblies. Since the declaration applies to ‘core components’, OEMs need granular material-level data from Tier-2 and Tier-3 suppliers—not just final product-level metrics.

Regulatory & Certification Service Providers

Consultancies, testing labs, and EPD verifiers will see increased demand for verification services aligned with ISO 14040/14044 and EN 15804. However, no official list of accredited verifiers under MedGreen has been published as of the regulation’s entry into force.

What Relevant Companies or Practitioners Should Focus On — And How to Respond Now

Monitor official guidance from German authorities and EU Commission

The regulation is newly effective; detailed implementation rules—including acceptable EPD standards, verification scope boundaries, and transitional arrangements—are not yet publicly available. Stakeholders should track updates from the German Federal Environment Agency (UBA) and the European Commission’s Medical Devices Coordination Group (MDCG).

Prioritize high-volume, high-risk product categories for initial EPD preparation

Given resource constraints, exporters should first assess devices with high material mass (e.g., MRI scanners, linear accelerators) or complex metal/plastic compositions (e.g., endoscopes, infusion pumps), where carbon footprint and recyclability calculations pose the greatest data-gathering challenges.

Distinguish between policy signal and enforceable obligation

While the regulation is legally binding, enforcement mechanisms—including penalties for non-compliance and timelines for market surveillance checks—have not been disclosed. Until clarification is issued, the requirement functions more as a procedural gate than an immediately auditable standard.

Initiate internal cross-functional alignment on data collection and supplier engagement

Manufacturers should convene procurement, R&D, and regulatory affairs teams to map raw material sourcing paths, identify gaps in supplier environmental reporting, and draft requests for upstream data (e.g., mill certificates with recycled content %, LCA reports). Early outreach helps avoid bottlenecks ahead of Q3 2026 deadlines.

Editorial Perspective / Industry Observation

Observably, this regulation represents an early national-level extension of the EU’s broader sustainability agenda into regulated health tech markets—preceding anticipated revisions to the EU Medical Device Regulation (MDR) on environmental criteria. Analysis shows it is less a standalone compliance endpoint and more a signal of converging regulatory expectations: environmental performance is now being treated as integral to safety and quality assessment. From an industry perspective, it reflects growing pressure to operationalize circularity metrics—not just as ESG disclosures, but as market access prerequisites. Current attention should focus less on whether the rule applies, and more on how its verification logic may inform future MDR amendments or parallel initiatives in France or the Netherlands.

Conclusion
This regulation marks a procedural shift—not yet a technical overhaul—for medical device exporters targeting Germany. It does not alter essential safety or performance requirements, but introduces a new, mandatory environmental data layer tied to market access. For stakeholders, it is best understood not as an isolated mandate, but as an early indicator of how sustainability criteria are becoming embedded within regulatory conformity frameworks across the EU healthcare sector.

Source Attribution
Main source: Official announcement by Germany’s Federal Ministry for the Environment, effective May 5, 2026.
Note: Implementation details—including approved EPD standards, verifier accreditation pathways, and enforcement timelines—remain pending official publication and are subject to ongoing observation.